VG 101 - BionovoAlternative Names: Seala; VG101
Latest Information Update: 12 Mar 2012
At a glance
- Originator Bionovo
- Mechanism of Action Selective estrogen receptor beta modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Atrophic vaginitis
Most Recent Events
- 12 Mar 2012 No development reported - Preclinical for Vaginal atrophy in USA (Vaginal)